PHA1A Clinical Trial - Plasma & Intrapulmonary Concentrations Study of WCK

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT06435936` - A Study to Assess the Safety of SAB-176 to Prevent the Flu, Given IM in Healthy Adults Compared With Placebo	Phase 1
	Recruiting	`NCT03931668` - Tolerance, PK and PD Effects Study of TPN-672 in Chinese Healthy Volunteers	Early Phase 1

See also

Status

Clinical Trial

Phase

Recruiting

NCT06435936 - A Study to Assess the Safety of SAB-176 to Prevent the Flu, Given IM in Healthy Adults Compared With Placebo

Phase 1

Recruiting

NCT03931668 - Tolerance, PK and PD Effects Study of TPN-672 in Chinese Healthy Volunteers

Early Phase 1

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT03630094
Study type	Interventional
Source	Wockhardt
Contact
Status	Completed
Phase	Phase 1
Start date	March 31, 2017
Completion date	July 30, 2017

Plasma and Intrapulmonary Concentrations Study of WCK 5222

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms